Most are β-thalassemia major (70.2%) and intermediate (26.9%), more than half of the intermediate can manifest as severe; β-thalassemia is more severe than β-thalassemia / HbE 208 mutation alleles were detected in 104 patients with β-thalassemia, with 13 mutations.